Lilly CEO: Monoclonal Antibody Companies Should Share Coronavirus Manufacturing Capacity

 
• By Derrick Gingery

David Ricks says a consortium of companies will be needed to ensure enough doses of the successful candidates are available.

Coronavirus globe
Monoclonal antibody treatment and manufacturing on the scale of a global pandemic has never been tried before, Lilly CEO David Ricks said. • Source: Shutterstock

More from Manufacturing

More from Compliance